The most important financial indicators for the company Mihmed Pharma Line Srl - Unique Identification Number 30592630:
sales in 2023 was
-
euro, registering a net profit of
-110
euro and having an average number of
employees.
Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Mihmed Pharma Line Srl - CUI 30592630
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
0
0
65
13.724
11.093
8.484
6.004
276
111
0
Current Assets
48.454
35.749
27.774
29.067
50.740
67.264
48.901
52.553
46.656
46.515
Inventories
1.650
1.903
1.281
5.144
2.454
2.373
2.328
1.464
1.421
1.416
Receivables
37.140
1.359
312
4.746
316
11.864
161
121
187
187
Cash
9.665
32.488
26.181
19.177
47.970
53.028
46.412
50.967
45.048
44.912
Shareholders Funds
24.093
30.294
27.839
42.007
61.567
65.684
53.494
46.435
46.428
46.177
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
25.800
6.422
0
795
267
10.081
1.412
6.394
338
337
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
46.515 euro in 2023 which includes Inventories of
1.416 euro, Receivables of
187 euro and cash availability of
44.912 euro.
The company's Equity was valued at
46.177 euro, while total Liabilities amounted to
337 euro.
Equity decreased by -110 euro, from 46.428 euro in 2022, to 46.177 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Mihmed Pharma Line Srl